A Recap: Consumer’s Guide to Generic Concerta


Please also see my latest comprehensive post on this topic:  Consumer Q&A on Concerta Generics.

Why the concern about the new generics for Concerta?  Here’s why.

It can take much trial and error to find the ADHD medication and dosage that works best for an individual. Once it’s found, it’s understandable that we don’t want it monkeyed with. So, when long-time Concerta users found that it had stopped working or was working less effectively, they were understandably alarmed. Some worried that they had “habituated” to the medication, but that is not typical for the stimulant medications. Others worried that something else was interfering—extra stress, a flu or cold, etc. Fortunately for some, they found the ADHD Roller Coaster blog and traced that change to their prescription being filled with one of the new generics.

I find it shocking that a pharmacy could change a patient’s medication so drastically with no warning. What’s worse, when some readers went back to their pharmacy,  pharmacists patted them on the head and assured them that generics are the same as brand. Not so!

It is true that generic medications generally work as well as brand, but they are not the exact same as brand. Here is an excerpt from a previous post on the topic (share it freely with any doubting pharmacists):

Moreover, as any experienced physician can tell you, generics can wreak havoc with that narrow “therapeutic window” — the dose that works best with the least side effects. A few milligrams up or down can mean trouble, and the FDA allows a wide window of efficacy.  In the U.S., the FDA  requires the bioequivalence of the generic product to be between 80% and 125% of that of the original product. Bioequivalence, however, does not mean that generic drugs must be exactly the same (“pharmaceutical equivalent”) as their original product counterparts, as chemical differences may exist.

The main reason, though, that many people are confused about the Concerta generics is that there are at least three generics within two distinct categories of generics. I’ll try to make this as simple as possible. Stay with me!

The first isn’t a generic at all but is the brand marketed as a generic (the “authorized generic”). The second is a generic in the true sense of the word (the “true generic”).

1. “Authorized generic” (Concerta offering from Watson/Actavis): An authorized generic is the brand drug marketed as a generic. The only difference is in price and name. Period.

Backstory: Watson struck a deal with Concerta’s manufacturer, Janssen: Watson would delay introducing their own generic to compete with Concerta if Janssen would manufacture and supply Watson with this brand-name Concerta, allowing it to market at a cheaper-than-brand price and give Janssen a piece of the profits.  This deal should last through 2014. (I wrote about this in detail here.)

Name on the Rx: methylphenidate hydrochloride extended-release tablets
Appearance: exactly the same as Concerta. A capsule imprinted with “alza” (the makers of Concert’s unique delivery-technology called OROS) and featuring a laser-drilled hole. (See photos below; color will vary with dosage strength)
Bottom line: If your generic Concerta is imprinted with “alza,” you have the brand medication. Period. Also, if you have one on hand, look for the little hole at the end; that tells you this capsule contains OROS, the laser-drilled osmotic pump that is the Concerta delivery-system technology.

The “authorized generic” marketed by Watson is the brand-name Concerta. To identify it, look for “alza” followed by the number of milligrams. The color varies by dosage strength, depicted below.

2. “True generic” (from Mallinckrodt and Kudco/Kremers-Urban, and perhaps more to come in the next few years):  This is a generic in the traditional sense, meaning a medication that is very similar to the brand and ostensibly works as well but is not the exact same as the brand.

Currently in the U.S., there are two “true generics” for Concerta. (Note: Another is available in Canada, Teva-Methylphenidate ER-C; Toronto-based Dr. Kenny Handelman discusses this generic on his blog.)

These generics are as follows:

A. Mallinckrodt began with only the 27 mg but now also markets its 36 mg and 54 mg generic Concerta.
Name on the Rx: methylphenidate hydrochloride extended-release tablets
Bottom line: This generic does not use brand-name Concerta’s OROS delivery system; you’ll see no laser-drilled hole on the end of these capsules, pictured below. Remember: It is the OROS delivery system that distinguishes Concerta.

Mallinckrodt’s generic of Concerta depicts an “M” in a square, followed by the milligrams; it does not use the OROS technology and instead appears to be more similar to Ritalin LA, a far less sophisticated delivery system. The color varies by dosage; I have a photo only of the 27 mg.

B. Kudco (Kremers-Urban)

Name on the Rx: methylphenidate hydrochloride extended-release tablets
Bottom line: As with the Mallinckrodt offering, this generic does not use brand-name Concerta’s OROS delivery system; you’ll see no laser-drilled hole on the end of these capsules, pictured below. Remember: It is the OROS delivery system that distinguishes Concerta.

The box looks like this (the color varies by dosage strength):

And the pills look like this, in the 18 and 27 milligram dosages:

Not Satisfied with Your “True” Generic? Here Are Your Options:

It is possible that, for some people, the generics might be preferable to the brand; the slight differences in action might work to your benefit.

If you have tried the “true generics” and found them unsatisfactory—or you’re not willing to gamble with the change—here are your options:

  1. ALWAYS check your pills before you pay for them. You typically cannot return them once you pay for them and especially after you leave the store.
  2. Ask your pharmacy to carry the Watson/Actavis/OROS authorized generic (same as brand)
  3. If the pharmacy refuses, call other pharmacies in your town.
  4. If your health insurance includes a mail-order option (typically, 60- or 90-day supply), ask if that pharmacy carries the OROS. If not, ask how much more the brand Concerta will be.   (Note: I find the mail-order option much easier; why go through the hassle 12 times annually if you can cut it to four or six?)
  5. Ask your physician to indicate “no substitutions” on the Rx script if the OROS generic is unavailable and you are willing to pay for the brand.
  6. Ask your physician to write a note to your health insurance company saying that you or your child experienced intolerable side effects to the generic and you must have brand. (Be prepared to pay the brand price, though.)
  7. Ask your physician to write “OROS only” on the prescription; Watson is in the process of changing names to Actavis, so most likely confusion will result if either name is used instead of OROS (the technology that makes Concerta unique).
  8. Complain to your health insurance carrier.

FINALLY: Please report any adverse side effects from “true generics”

Above all, if you or your child experienced adverse reactions to the Mallinckrodt or Kudco/Kremers-Urban generics of Concerta (and have not had such reactions to the brand/”authorized generic” Concerta), please do yourself and everyone else a favor:  File a complaint here with the FDA’s MedWatch (scroll down to the box that says “consumer”).

If the FDA receives sufficient data that a medication merits investigating, it will do so. A generic of Wellbutrin XL was recently recalled after such an effort (explained in this previous post).

I hope this answers some questions and settles the confusion!

Please subscribe to this blog to be notified of updates on this continuing saga.

For more background, see this post (“What’s Up with Generic Concerta?”)

Gina Pera, author and Adult ADHD expert

For more information on Adult ADHD and its treatment strategies, including how to get best results from your medication, please consult my book‘s three chapters on the topic.


  1. kerry constantine says

    Thanks so much! Couldn’t figure out why my son’s meds weren’t working until I saw that the FDA put the generic Concerta on the watch list. Your blog explains the difference perfectly to me. Come to find out the pharmacy stopped carrying the “real” generic because of profitability issues. I called my son’s physician to get a new script. Now what to do with a 60 day supply of medicine that is way to short acting? Might as well be on Ritalin for how long this generic it works.

    • says

      Good question, Kerry. I guess you could keep it in case of an emergency where something would be better than nothing (but not by much).

      Yes, definitely. It’s a profit issue. That’s why I have such disdain for the slimeballs that foisted these inferior products on a vulnerable public. It’s pure sociopathy, in my opinion.


  2. kerry constantine says

    Hi Gina:
    I printed your article and took it to my son’s pediatrician this afternoon. He said he hadn’t seen an issue with generic medications in the last 5 years but questioned how the Mallinckro generic could even be marketed as Concerta without the OROS. He wrote a new script for Concerta brand or Watson/Actavis generic brand only. I called around to pharmacies to make sure that the pharmacy had the Watson/Actavis brand. Got to the pharmacy only to have the insurance reject the new prescription due to the fact that I have roughly a 60 day supply of the Mallincko junk (of course they told me yesterday on the phone I wouldn’t have an issue). I explained the situation to my insurance company and they are trying to override their denial to get the new script to go through but they indicated that I may need to return the supply I have to the pharmacy that issued it. What a nightmare to put a parent and child through! This last month was state-wide standardized testing and probably the most important month of my son’s school year. The FDA needs to pull this generic altogether to protect consumers and especially children. Additionally, pharmacies need to do the right thing and quit carrying the Mallinckro generic Concerta medications.

    • says

      Hi Kerry,

      Ach! That’s awful!

      No offense to your MD, but the generics for ADHD meds have a long history of being problematic.

      Marketing a generic Concerta that doesn’t incorporate OROS is precisely the problem, as I’ve written in the several blog posts devoted to this topic. It’s outrageous that these manufacturers got away with it. I’m still trying to figure it out and can’t get any straight answers.

      If you send an e-mail to me, I’ll be happy to reply with the PDF of the Medscape article; you can forward that to your insurance company. Maybe it would help. Look for “contact” at the top of this blog’s homepage.

      Good luck!

  3. says

    We tried our daughter on some kind of Concerta a year ago. I don’t know what we actually received from the pharmacy; I’ll need to find out. She became far more angry and confrontational on the medication. We quit and haven’t tried another one since.

    Now I’m the guinea pig. Tried Adderall; had positive effect for the first 3-4 hours, but by 5 hours after the morning dose, life was hell. I have another appointment with the doctor in 1/2 hour to discuss medicine options. THANK YOU SO MUCH FOR YOUR BOOK AND BLOG!!!!!! I’m willing to give stimulants a chance because of the information I’ve gleaned through your work. Thank you, thank you, thank you!

    • says

      You’re welcome, Ellen.

      Remember the co-existing conditions, such as depression and anxiety, can be exacerbated by the stimulants.

      When they are present, there needs to be a two-pronged approach.

    • says

      I’m now in possession of the 18 mg Watson generic. Had I not read this blog post, I would have received the Mallinckrodt generic. That’s what the pharmacy filled even though my doctor wrote “Brand only” on the prescription! They didn’t have the brand, but did have both generics and did redo their work to give me the Watson.

      Rather shocking to have to be so diligent all the way through the process: convincing my doctor that I wouldn’t continue with Adderall; having to point out to the pharmacy their mistake in filling a “brand only” prescription w/ a generic; asking for the authenticated generic only to be asked, “What do you mean by that?” by the pharmacist. All interaction was pleasant — and, on my part, persistent! — throughout. YAY! I’ve learned to be pleasant and persistent at the same time!

      The plan now is to take 18 mg of Concerta for fourteen days, then titrate up to 27 mg for another 14 days, then have an appointment with the doctor and possibly titrate up to 36 mg. Not feeling much, if any, benefit yesterday and today, but also not experiencing any negative side effects. Should I wait out the 14 day trial of 18 mg, or might it be acceptable to beg ask my doctor to titrate up after a week?

      Thanks again for all your work. I’ll be starting all my Amazon searches through your site!

    • says

      Hi Ellen — Congrats on being an informed consumer and not being cowed. 😉

      The main thing, as you are trying the medication, is to be very deliberate about it. Try to do things that you cannot normally do (due to ADHD symptoms): e.g. read a dull magazine article, etc. You need real data, not just “oh, I feel better.”

      Slow and steady wins the race.

      Thanks for using my link!

    • says

      Well, I had a depressive episode this afternoon for which there was no apparent cause. I’m on 150 mg of Bupropion and 15 mg of Deplin for the depression, which manages it well. Concerta appears to be throwing a spanner in the works. Do you know if people ever get past having their depression exacerbated by ADHD stimulants?

    • says

      Ellen, yes, depression coexisting with ADHD can be well-managed.

      The problem is that “depression” is such a squishy word.

      And if you’re taking Bupropion, that is an atypical antidepressant that also targets dopamine. So, you might be getting too much on the “stimulant” end of things.


  4. says

    This is absolutely true what you’re saying. For one thing if you think about it when they make these pills they can come out at slightly different MG’s, besides that because the ingredients are sourced from different places and can therefore probably not have the same exact effectiveness at all times.
    The other reason this makes sense is because sometimes not using a big brand name can indeed to be a sort of knock off which isn’t as good as the original brand. Really interesting info learning about these specific differences though, thanks.

  5. says

    We are having very similar issues with the generic Concerta that is available in Canada Teva Methylphenidate ER-C. To access additional information on this please go to the CADDAC, Centre for ADHD Awareness Canada web site and access information under ADHD info, medication, generic medication substitution, http://www.caddac.ca/cms/page.php?119. Kenny Handelman’s blog on the topic is also excellent. We are currently surveying medical practitioners to discover how much of an issue they are finding generic mental health medications. It seems that sensitivities to alterations in mental health medications are greater and cause more fallout than with other medications. If you would like to let CADDAC know about issues that you have had or are having with generic medication please contact me at heidi.bernhardt@caddac.ca. We also encourage patients to report issues with less efficacy or increased side effects to Health Canada. Health Canada has let us know that nothing will be done unless they hear from enough people. For more info on this please access http://www.caddac.ca/cms/page.php?230.

    Heidi Bernhardt
    President and Executive Director CADDAC

  6. A. Silken says

    As of 11-13-2014, the FDA has now concurred with concerns about two of the three generic Concertas. See link below.


    “The FDA has changed the therapeutic equivalence (TE) rating for the Mallinckrodt and Kudco products from AB to BX. This means the Mallinckrodt and Kudco products are still approved and can be prescribed, but are no longer recommended as automatically substitutable at the pharmacy (or by a pharmacist) for Concerta.”

    Unfortunately, pharmacies are now refusing to dispense any generic Concerta, including Watson/Activis OROS tablets, based on the false assumption that all generics are affected by the FDA ruling. Also, unfortunately, most doctors are not yet aware of this.

  7. Ann Adams says

    My son was given the Mallinkrodt brand and has had headaches and stomach aches. It’s horrible when compared to the Watson brand Methyphenidate. This really concerns me that the pharmacy wanted to argue this with me at first thank God for your blog I am getting it switched back but it has been a pain to do this. Watson brand seems to be good!

  8. mark says

    Seems like enough harm for a class action lawsuit. Imagine a child’s initial exposure to Kudco ER methylphenidate versus an Actavis version. That case scenario would be parent and child reporting and experiencing an utter failure when in fact there was help actually in the OROS version.
    If Kudco knows this (the pharmacies also), as well as Kudco’s failure to comply with the FDA’s request for bioequivalence study: …” From Princeton, NJ – Nov. 14, 2014– Kremers Urban Pharmaceuticals Inc. (KU) has been informed by the U.S. Food and Drug Administration (FDA) that the agency requests an additional bioequivalence study based on recently issued draft guidance to confirm the therapeutic equivalence of the company’s methylphenidate hydrochloride
    extended-release (ER) tablets (CII) to the category reference drug.”… then lets set a precedent.

    • says

      I’m no attorney, but I would agree with you, Mark.

      The bigger “800-pound gorilla” is Mallinckrodt, which is defying FDA rulings. Shockingly brazen, if you ask me.

      I’ll have a follow-up post soon. The six month period given to the two companies (Mallinckrodt and KU) ended this week. KU has withdrawn. M not so, and pharmacies (especially CVS, it seems) are still substituting it for brand.

      I’ve posted several notices on Twitter, but don’t know if anyone’s paying attention.



Leave a Reply

Your email address will not be published. Required fields are marked *